CGNH logo

CardioGenics Holdings Inc Stock Price

OTCPK:CGNH Community·US$142.0 Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

CGNH Share Price Performance

US$0.000001
0.00 (0.00%)
US$0.000001
0.00 (0.00%)
Price US$0.000001

CGNH Community Narratives

There are no narratives available yet.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

CardioGenics Holdings Inc Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$980.8k

Other Expenses

-US$980.8k

Earnings

Last Reported Earnings
Jan 31, 2016
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About CGNH

Founded
1997
Employees
n/a
CEO
Yahia Gawad
WebsiteView website
www.cardiogenics.com

CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.

Recent CGNH News & Updates

No updates

Recent updates

No updates